Price
Financials
Standalone, Rs crore| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|---|
| Sales | 28 | 20 | 12 | 18 | 22 | 93 | 85 |
| Expenses | 26 | 28 | 36 | 38 | 34 | 93 | 92 |
| Operating Profit | 2 | -7 | -24 | -20 | -11 | -0 | -7 |
| OPM % | 8% | -37% | -209% | -109% | -51% | -0.0% | -8% |
| Other Income | -2 | 1 | 1 | 1 | 4 | 0 | 1 |
| Interest | 2 | 2 | 2 | 0 | 2 | 0 | 1 |
| Depreciation | 2 | 3 | 2 | 3 | 5 | 13 | 12 |
| Profit before tax | -3 | -12 | -28 | -22 | -14 | -13 | -19 |
| Tax % | 121% | -49% | 1% | 1% | 0% | 0% | 0% |
| Net Profit | -8 | -6 | -28 | -23 | -14 | -13 | -19 |
| EPS in Rs | |||||||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 12% | % | % | -8% | ||
| Compounded Profit Growth | % | % | % | -41% | ||
| Stock Price CAGR | % | % | % | % | ||
| Return on Equity | % | % | % | -19% |
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 89 | 101 | 101 | 218 | 218 |
| Reserves | -1 | -7 | -36 | -58 | -72 | -128 | -107 |
| Borrowings | 22 | 49 | 3 | 13 | 44 | 9 | 10 |
| Other Liabilities | 14 | 9 | 15 | 36 | 34 | 87 | 89 |
| Total Liabilities | 44 | 61 | 71 | 92 | 108 | 186 | 210 |
| Fixed Assets | 28 | 26 | 41 | 56 | 73 | 102 | 87 |
| CWIP | 4 | 25 | 16 | 15 | 3 | 0 | 6 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 12 | 9 | 15 | 21 | 32 | 84 | 118 |
| Total Assets | 44 | 61 | 71 | 92 | 108 | 186 | 210 |
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 3 | -6 | -17 | 1 | -18 | ||
| Cash from Investing Activity | -5 | -20 | -11 | -22 | -10 | ||
| Cash from Financing Activity | 2 | 25 | 30 | 23 | 29 | ||
| Net Cash Flow | -0 | -0 | 2 | 1 | 1 | ||
| Free Cash Flow | -3 | -25 | -36 | -21 | -28 | ||
| CFO/OP | 126% | 75% | 70% | -6% | 157% |
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2015 | Mar 2016 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 69 | 52 | 64 | 81 | 97 | 114 | 107 |
| Inventory Days | 272 | 186 | 294 | 237 | 436 | 278 | 211 |
| Days Payable | 358 | 384 | 984 | 2,090 | 1,288 | 209 | 177 |
| Cash Conversion Cycle | -17 | -146 | -626 | -1,773 | -756 | 183 | 140 |
| Working Capital Days | 54 | -2 | -78 | -358 | -106 | -65 | -144 |
| ROCE % | -23% | -48% | -39% | -18% | -16% |
Fundamentals
Market Cap₹ Cr.
Current Price₹
Book Value₹
ROCE-16.3 %
ROE-18.7 %
Dividend Yield%
Face Value₹ 10.0
Compounded Sales Growth (TTM)-8%
Compounded Profit Growth (TTM)-41%
Standalone figures.
Profitability
Operating margin (excl. other income)-108.95%
Operating margin (incl. other income)-102.40%
EBITDA margin-102.40%
Pre-tax margin-122.11%
Net profit margin-122.93%
ROE-46.81%
ROCE-39.23%
ROA-27.64%
ROE, 3-year average-88.18%
ROCE, 3-year average-36.91%
ROA, 3-year average-27.41%
ROIC (approx.)-41.76%
Tax rate-0.67%
Other income / net worth2.78%
Growth
Sales growth (latest year)58.20%
Sales CAGR, 3 years-13.53%
Per share
EPS (TTM)Rs -2.22
EPS (latest year)Rs -2.22
EPS, 3-year averageRs -3.98
Book value per shareRs 4.26
Sales per shareRs 1.81
Cash flow per shareRs 0.10
Free cash flow per shareRs -2.76
Efficiency
Asset turnover0.20x
Fixed asset turnover0.33x
Inventory turnover4.89x
Inventory days75 days
Debtor days81 days
Debtors turnover4.50x
Creditor days177 days
Cash conversion cycle140 days
Working capital days-144 days
Leverage
Total debtRs 13 Cr
Cash and bankRs 3 Cr
Net debtRs 10 Cr
Debt to equity0.30x
Interest coverage-51.02x
Owners' fund to total sources46.84%
Debt to assets14.08%
Cash flow
Cash from Operating Activity (latest year)Rs 1 Cr
Cash from Investing Activity (latest year)Rs -22 Cr
Cash from Financing Activity (latest year)Rs 23 Cr
Net Cash Flow (latest year)Rs 1 Cr
Free cash flow (latest year)Rs -28 Cr
FCFE (approx.: FCF + change in debt)Rs -18 Cr
Sales to cash flow17.62x
Statement figures
Net sales (TTM)Rs 18 Cr
Net sales (latest year)Rs 18 Cr
Operating profit excl. other income (latest year)Rs -20 Cr
Other income (TTM)Rs 1 Cr
EBITDA (TTM)Rs -19 Cr
PBDT (TTM)Rs -19 Cr
Profit before tax (TTM)Rs -22 Cr
Tax (latest year)Rs 0 Cr
Net profit (TTM)Rs -23 Cr
Net profit (latest year)Rs -23 Cr
Depreciation (TTM)Rs 3 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 18 Cr
Total expenditure (latest year)Rs 38 Cr
Total income (latest year)Rs 20 Cr
Share capitalRs 101 Cr
ReservesRs -58 Cr
Shareholders' fundsRs 43 Cr
Total assetsRs 92 Cr
Net blockRs 56 Cr
Capital work in progressRs 15 Cr
ReceivablesRs 4 Cr
InventoryRs 4 Cr
Other liabilitiesRs 36 Cr
Shares outstanding (crore)10.14
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.
Red flags
F-score 5 of 8| explain | Receivables outrunning sales Receivables grew 100% vs sales +58% in 2016 |
| explain | Share dilution Share count up 14% in a year, 992% in three |
| look | Repeated losses Net loss in each of the last two years |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
No quarterly results published.
Activity
CompareNo listed peers in this industry.
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Capsugel Healthcare Ltd?
Capsugel Healthcare Ltd (506887) has a market capitalisation of Rs Cr. at the close.